A citation-based method for searching scientific literature

Kian-Keong Poh, Ping Lu, Gangjian Qin, Marcy Silver, Douglas W Losordo, Michael E Mendelsohn, Yan Zhu. Int J Cardiol 2013
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Study of the intima-media thickening in carotid arteries of healthy elderly with high blood pressure and elderly with high blood pressure and dyslipidemia.
Elizabete Viana de Freitas, Andréa Araújo Brandão, Roberto Pozzan, Maria Eliane Magãlhies, Márcia Castier, Airton Pires Brandão. Clin Interv Aging 2008
11
50

Endothelial dysfunction in hypertension.
P Puddu, G M Puddu, F Zaca, A Muscari. Acta Cardiol 2000
108
50

Essential hypertension.
Jan A Staessen, Jiguang Wang, Giuseppe Bianchi, Willem H Birkenhäger. Lancet 2003
304
50

Vascular calcification and hypertension: cause and effect.
Sundeep S Kalra, Catherine M Shanahan. Ann Med 2012
56
50



Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community.
Ravi Dhingra, Michael J Pencina, Peter Schrader, Thomas J Wang, Daniel Levy, Karol Pencina, Deborah A Siwik, Wilson S Colucci, Emelia J Benjamin, Ramachandran S Vasan. Circulation 2009
46
50

Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.
Stephen F Rodrigues, Edward D Tran, Zuleica B Fortes, Geert W Schmid-Schönbein. Am J Physiol Heart Circ Physiol 2010
61
50

Hypertension and endothelial dysfunction: therapeutic approach.
Lorenzo Ghiadoni, Stefano Taddei, Agostino Virdis. Curr Vasc Pharmacol 2012
94
50

Hypertension: how does management change with aging?
Milta O Little. Med Clin North Am 2011
6
50

Circulating matrix metalloproteinases and their inhibitors in hypertension.
Vanessa Fontana, Pamela S Silva, Raquel F Gerlach, Jose E Tanus-Santos. Clin Chim Acta 2012
54
50





Blood pressure and vascular calcification.
Nicole E Jensky, Michael H Criqui, Michael C Wright, Christina L Wassel, Steven A Brody, Matthew A Allison. Hypertension 2010
64
50

Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia.
Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, Sibilla A T Salvadeo, Ilaria Ferrari, Elena Fogari, Alessia Gravina, Roberto Mereu, Ilaria Palumbo, Sabrina Randazzo,[...]. Clin Invest Med 2009
32
50

Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.
P R Nagareddy, P S Rajput, H Vasudevan, B McClure, U Kumar, K M Macleod, J H McNeill. Br J Pharmacol 2012
28
50

Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling.
Stéphanie Lehoux, Catherine A Lemarié, Bruno Esposito, H Roger Lijnen, Alain Tedgui. Circulation 2004
112
50

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
Hossein-Ardeschir Ghofrani, Andrea M D'Armini, Friedrich Grimminger, Marius M Hoeper, Pavel Jansa, Nick H Kim, Eckhard Mayer, Gerald Simonneau, Martin R Wilkins, Arno Fritsch,[...]. N Engl J Med 2013
721
50

Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
Diana Bonderman, Stefano Ghio, Stephan B Felix, Hossein-Ardeschir Ghofrani, Evangelos Michelakis, Veselin Mitrovic, Ronald J Oudiz, Francis Boateng, Andrea-Viviana Scalise, Lothar Roessig,[...]. Circulation 2013
196
50

Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.
Yasuko Nagasaka, Emmanuel S Buys, Ester Spagnolli, Andrea U Steinbicker, Sarah R Hayton, Kristen M Rauwerdink, Peter Brouckaert, Warren M Zapol, Kenneth D Bloch. Am J Physiol Heart Circ Physiol 2011
20
50

Structure and regulation of soluble guanylate cyclase.
Emily R Derbyshire, Michael A Marletta. Annu Rev Biochem 2012
265
50


Higher-order interactions bridge the nitric oxide receptor and catalytic domains of soluble guanylate cyclase.
Eric S Underbakke, Anthony T Iavarone, Michael A Marletta. Proc Natl Acad Sci U S A 2013
47
50

Receptor binding assay for NO-independent activators of soluble guanylate cyclase.
Peter M Schmidt, Johannes-Peter Stasch. Methods Mol Biol 2013
2
50

Riociguat for the treatment of pulmonary arterial hypertension.
Hossein-Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi-Cheng Jing, Anne M Keogh, David Langleben, Michael Ochan Kilama, Arno Fritsch,[...]. N Engl J Med 2013
737
50

Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
Chien-nien Chen, Geoffrey Watson, Lan Zhao. Vascul Pharmacol 2013
12
50

Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure.
Erland Erdmann, Marc J Semigran, Markku S Nieminen, Mihai Gheorghiade, Rahul Agrawal, Veselin Mitrovic, Alexandre Mebazaa. Eur Heart J 2013
98
50

Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension.
Edward A Pankey, Adeleke M Badejo, David B Casey, George F Lasker, Russel A Riehl, Subramanyam N Murthy, Bobby D Nossaman, Philip J Kadowitz. Nitric Oxide 2012
26
50

Acute antihypertensive action of Tempol in the spontaneously hypertensive rat.
Xueguang Chen, Kinjal Patel, Stephanie G Connors, Margarida Mendonca, William J Welch, Christopher S Wilcox. Am J Physiol Heart Circ Physiol 2007
37
50

Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity.
Erin J Heckler, Pierre-Antoine Crassous, Padmamalini Baskaran, Annie Beuve. Biochem J 2013
16
50


Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Sevil Korkmaz, Sivakkanan Loganathan, Beatrice Mikles, Tamás Radovits, Eniko Barnucz, Kristóf Hirschberg, Shiliang Li, Peter Hegedüs, Szabolcs Páli, Alexander Weymann,[...]. J Cardiovasc Pharmacol Ther 2013
16
50

Sulfhydryl-dependent dimerization and cGMP-mediated vasodilatation.
Dou Dou, Xiaoxu Zheng, Lei Ying, Liping Ye, Yuansheng Gao. J Cardiovasc Pharmacol 2013
6
50

sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.
Emmanuel S Buys, Anje Cauwels, Michael J Raher, Jonathan J Passeri, Ion Hobai, Sharon M Cawley, Kristen M Rauwerdink, Helene Thibault, Patrick Y Sips, Robrecht Thoonen,[...]. Am J Physiol Heart Circ Physiol 2009
36
50

Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses.
Brandi M Wynne, Hicham Labazi, Rita C Tostes, R Clinton Webb. Pharmacol Res 2012
21
50

Soluble guanylate cyclase modulates alveolarization in the newborn lung.
Patricia R Bachiller, Katherine H Cornog, Rina Kato, Emmanuel S Buys, Jesse D Roberts. Am J Physiol Lung Cell Mol Physiol 2013
24
50

Mechanism of inhibition of tubuloglomerular feedback by CO and cGMP.
Yilin Ren, Martin A D'Ambrosio, Jeffrey L Garvin, Hong Wang, Oscar A Carretero. Hypertension 2013
6
50

Mechanisms of carbon monoxide attenuation of tubuloglomerular feedback.
Yilin Ren, Martin A D'Ambrosio, Hong Wang, John R Falck, Edward L Peterson, Jeffrey L Garvin, Oscar A Carretero. Hypertension 2012
6
50


HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.
Jennifer C Irvine, Nga Cao, Swati Gossain, Amy E Alexander, Jane E Love, Chengxue Qin, John D Horowitz, Barbara K Kemp-Harper, Rebecca H Ritchie. Am J Physiol Heart Circ Physiol 2013
24
50

Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial.
Marius M Hoeper, Michael Halank, Heinrike Wilkens, Andreas Günther, Gerrit Weimann, Irmingard Gebert, Hanno H Leuchte, Jürgen Behr. Eur Respir J 2013
92
50

The ventral hippocampus NMDA receptor/nitric oxide/guanylate cyclase pathway modulates cardiovascular responses in rats.
Cibele O Santini, Aline Fassini, América A Scopinho, Cristiane Busnardo, Fernando M A Corrêa, Leonardo B M Resstel. Auton Neurosci 2013
11
50


Chronic oxidative-nitrosative stress impairs coronary vasodilation in metabolic syndrome model rats.
Satomi Kagota, Kana Maruyama, Yukari Tada, Kazuhito Fukushima, Keiji Umetani, Hirokazu Wakuda, Kazumasa Shinozuka. Microvasc Res 2013
13
50

Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.
Binglan Yu, Mohd Shahid, Elena M Egorina, Mikhail A Sovershaev, Michael J Raher, Chong Lei, Mei X Wu, Kenneth D Bloch, Warren M Zapol. Anesthesiology 2010
58
50

Increased caveolae density and caveolin-1 expression accompany impaired NO-mediated vasorelaxation in diet-induced obesity.
T Hilton Grayson, Preet S Chadha, Paul P Bertrand, Hui Chen, Margaret J Morris, Sevvandi Senadheera, Timothy V Murphy, Shaun L Sandow. Histochem Cell Biol 2013
20
50

Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.
Robrecht Thoonen, Patrick Y Sips, Kenneth D Bloch, Emmanuel S Buys. Curr Hypertens Rep 2013
28
50

Dietary obesity increases NO and inhibits BKCa-mediated, endothelium-dependent dilation in rat cremaster muscle artery: association with caveolins and caveolae.
Lauren Howitt, T Hilton Grayson, Margaret J Morris, Shaun L Sandow, Timothy V Murphy. Am J Physiol Heart Circ Physiol 2012
22
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.